Shareholders approve reverse stock split authorization for ProMIS Neurosciences

ProMIS Neurosciences Inc.

Special meeting on Nov 17, 2025; 24.3M of 53.8M shares voted (45% quorum).
Share Consolidation Proposal approved: 21,331,321 for, 2,939,187 against.
Board authorized to effect 1:5 to 1:25 reverse split within one year at its discretion.
Adjournment proposal also passed with 22.3M in favor.
No broker non-votes; action allows potential Nasdaq compliance maintenance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.